Skip to main content
ToolsForensic AnalysisASCENDIS PHARMA

ASCENDIS PHARMA

Supplier Forensic Analysis · Scanned: 2026/07/29

Open this supplier in the workbench →

These findings identify statistical unusualness and named data patterns for review. They do not establish wrongdoing and require source verification.

CIPC screening
Clear
Compliance
N/A/100
Awards
4
Total Value
R 505M

Recent Awards

4 awards · Total: R 505 419 512,59

Showing 5 of 4
SUPPLY AND DELIVERY OF CONTRACEPTIVES AND HORMONE MODULATING AGENTS TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 01 OCTOBER 2026 TO 30 SEPTEMBER 2029
Health and Welfare Sector Education and Training Authority
Ref: HP03-2026CHM
R 376 808 964,00
22 Jun 2026
HP02-2025AI: Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2025 to 30 September 2028.
Health
Ref: HP02-2025AI
R 3 491 784,80
21 Aug 2025
Supply and Delivery of Small Volume Parenterals and Insulin Devices to the Department of Health for the period ending 30 April 2027.
Health
Ref: HP06-2024SVP/01
R 69 498 377,54
24 Oct 2024
Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2023 to 30 September 2025
Health
Ref: HP02-2023AI
R 55 620 386,25
15 Jun 2023

AI Analysis

Powered by Gemini

AI Forensic Analysis

Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo

or upgrade to Pro Subscription

Procurement context

Competitive concentration, procurement-intelligence context, province health, and restricted-supplier status are available to forensic subscribers.

Unlock forensic context →
CIPC screening signalsClear

No contributing warning signals in the current evidence.

Unlock Full Analysis

Get access to all forensic flags, evidence details, and AI-generated audit narratives.

View Full Intelligence Report

Get complete award history, director network, and compliance analysis.

View Report →